Pier 1 Imports offered to issue 0.6 of its share for every share of Cost Plus, which implies a price of $4 per share or approximately $81 million. The offer is 31% higher than Cost Plus' closing share price on Friday and 34% higher than the company's 30-day average share price. Share of Cost Plus, which closed at $3.05 on Friday, opened at $3.77 on Monday and in noontime trading stood at $3.58, up more than 17% on the day. Pier 1 Shares opened at $6.50 and was down to $6.00 in noontime trading, off approximately 10%.

Asking to meet with Cost Plus executives today, Pier One president/chief executive Alex Smith states in the letter that the combination will result in improvements in Cost Plus's operating margins through organizational efficiencies in the supply chain management, shared services, store operations and other general administrative costs. Smith suggests that it can achieve costs savings for Cost Plus in the range of 5% of sales (approximately $50 million). In addition, he says Cost Plus shareholders, who would need to approve the transaction, would enjoy improved operational liquidity and a more active trading market for their shares.

"We are prepared to deliver a draft merger agreement to you and begin discussions immediately," states Smith in a letter to Cost Plus' Board of Directors. "We have engaged JPMorgan as our financial advisor for this purpose, as well as outside legal counsel. Our team is prepared to devote the additional significant resources necessary to ensure a smooth and expedited process."


Pier 1 in Dallas

Absent a transaction, Smith says Cost Plus is "likely to face increasing liquidity problems" while "Pier 1's financial condition is sound." Indeed, he says Pier One committed a $450-million asset-based lending facility that should be sufficient to provide future operational liquidity for both companies.

"We are confident that Cost Plus shareholders would prefer a combined company focused on long-term growth and profitability rather than a stand-alone Cost Plus preoccupied with simply reaching positive cash flow," Smith says. "Our preference is to work together with you and your advisors to negotiate and announce a definitive agreement between our companies in the near term. Our antitrust counsel has advised us that the antitrust review process should be straightforward."

That having been said, Pier One also offered a warning. "We note that Cost Plus currently has in place a shareholder rights plan (or poison pill) that is scheduled to expire on June 30, 2008," Smith states. "As a shareholder of Cost Plus, please consider this our formal request that you terminate that shareholder rights plan immediately and that you refrain from renewing or extending it or adopting any other rights plan or poison pill. In addition to your fiduciary duty to shareholders, who should have the right to decide for themselves whether a transaction is in their best interests as owners of Cost Plus, we believe that the Cost Plus shareholder rights plan is a discriminatory rights plan that violates Section 203 of the California Corporations Code."

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM Digital Member, you’ll receive:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.